이 누리집은 대한민국 공식 전자정부 누리집입니다.
Biz News Korea(Eng)
- Collected
- 2019.07.25
- Distributed
- 2019.07.26
- Source
- Go Direct
South Korea’s leading asset manager Mirae Asset Global Investments Co. announced Thursday that its Hong Kong subsidiary listed two exchange-traded funds (ETFs) tracking biotech companies and cloud computing industry in China on the Hong Kong Stock Exchange.
The Mirae Asset Horizons China Biotech ETF invests in companies expected to lead the China’s biotechnology and bioengineering industry. Biotechnology is a technology that uses biological systems and living organisms to solve problems and make useful products such as drugs.
The research division of Mirae Asset’s Hong Kong subsidiary predicted that the biotech market would be boosted by the Chinese government’s Made in China 2025 initiative aimed at shifting Chinese economy into high value-added sectors. The biopharmaceutical market in China is expected to grow by 18 percent per year on average by 2023.
The Mirae Asset Horizons China Cloud Computing ETF invests in the cloud computing industry that is forecast to expand more than 30 percent annually by 2023. Cloud computing is one of the core technologies of the fourth industrial revolution, which enables on-demand availability of computing power, data and related services that can be retrieved from databases anytime. The Chinese cloud computing market currently estimated at worth around 6 trillion won ($5.1 billion) has a huge growth potential as it is still in its early stage.
The two ETFs track 20 stocks each and have an investment limit of 6 percent for each sector. The investment can be made both the U.S. dollar and Hong Kong dollar, and Korean investors can also invest in the funds via brokerages handling overseas equity investment.
By Kim Je-lim and Choi Mira
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]